25 XP   0   0   10

Bioqual Inc
Buy, Hold or Sell?

Let's analyse Bioqual together

PenkeI guess you are interested in Bioqual Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioqual Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.

Quick analysis of Bioqual (30 sec.)










What can you expect buying and holding a share of Bioqual? (30 sec.)

How much money do you get?

How much money do you get?
$0.50
When do you have the money?
1 year
How often do you get paid?
67.5%

What is your share worth?

Current worth
$43.41
Expected worth in 1 year
$43.98
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
$1.07
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
$72.50
Expected price per share
$72.50 - $75.00
How sure are you?
50%

1. Valuation of Bioqual (5 min.)




Live pricePrice per Share (EOD)

$72.50

Intrinsic Value Per Share

$39.31 - $284.48

Total Value Per Share

$82.72 - $327.89

2. Growth of Bioqual (5 min.)




Is Bioqual growing?

Current yearPrevious yearGrowGrow %
How rich?$38.8m$38.6m-$249.2k-0.6%

How much money is Bioqual making?

Current yearPrevious yearGrowGrow %
Making money$239.2k$856.3k-$617k-257.9%
Net Profit Margin1.6%4.7%--

How much money comes from the company's main activities?

3. Financial Health of Bioqual (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#90 / 144

Most Revenue
#90 / 144

Most Profit
#64 / 144

What can you expect buying and holding a share of Bioqual? (5 min.)

Welcome investor! Bioqual's management wants to use your money to grow the business. In return you get a share of Bioqual.

What can you expect buying and holding a share of Bioqual?

First you should know what it really means to hold a share of Bioqual. And how you can make/lose money.

Speculation

The Price per Share of Bioqual is $72.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioqual.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioqual, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $43.41. Based on the TTM, the Book Value Change Per Share is $0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $0.71 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioqual.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.310.4%0.270.4%0.961.3%1.041.4%0.921.3%
Usd Book Value Change Per Share0.310.4%0.140.2%0.711.0%0.811.1%0.781.1%
Usd Dividend Per Share0.000.0%0.130.2%0.500.7%0.670.9%0.510.7%
Usd Total Gains Per Share0.310.4%0.270.4%1.211.7%1.492.0%1.291.8%
Usd Price Per Share70.00-68.75-80.00-67.93-43.68-
Price to Earnings Ratio56.91-19.60-3.07-12.25-9.43-
Price-to-Total Gains Ratio227.65-78.39-7.51-39.29-36.54-
Price to Book Ratio1.61-1.60-1.85-1.87-1.41-
Price-to-Total Gains Ratio227.65-78.39-7.51-39.29-36.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share72.5
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.67
Usd Book Value Change Per Share0.140.81
Usd Total Gains Per Share0.271.49
Gains per Quarter (13 shares)3.4819.32
Gains per Year (13 shares)13.9177.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1774354267
21315187085144
3202232105127221
4263046140169298
5333760175211375
6394474210254452
7465288245296529
85259102280338606
95967116315381683
106574130350423760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%65.05.00.092.9%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%35.03.02.087.5%59.09.02.084.3%
Dividend per Share1.00.03.025.0%6.00.06.050.0%14.00.06.070.0%27.00.013.067.5%40.00.030.057.1%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%37.03.00.092.5%62.08.00.088.6%

Fundamentals of Bioqual

About Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Fundamental data was last updated by Penke on 2024-05-14 15:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bioqual Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioqual earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 1.8% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioqual Inc:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 1.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.6%+0.2%
TTM1.6%YOY4.7%-3.1%
TTM1.6%5Y6.8%-5.3%
5Y6.8%10Y7.6%-0.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-7.8%+9.6%
TTM1.6%-6.9%+8.5%
YOY4.7%-2.3%+7.0%
5Y6.8%-2.5%+9.3%
10Y7.6%-2.3%+9.9%
1.1.2. Return on Assets

Shows how efficient Bioqual is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • 0.5% Return on Assets means that Bioqual generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioqual Inc:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.4%+0.1%
TTM0.4%YOY1.3%-0.9%
TTM0.4%5Y1.9%-1.5%
5Y1.9%10Y2.7%-0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%-1.5%+2.0%
TTM0.4%-1.1%+1.5%
YOY1.3%-0.6%+1.9%
5Y1.9%-0.3%+2.2%
10Y2.7%-0.4%+3.1%
1.1.3. Return on Equity

Shows how efficient Bioqual is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • 0.7% Return on Equity means Bioqual generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioqual Inc:

  • The MRQ is 0.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.6%+0.1%
TTM0.6%YOY2.2%-1.6%
TTM0.6%5Y3.1%-2.5%
5Y3.1%10Y3.7%-0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-0.3%+1.0%
TTM0.6%0.2%+0.4%
YOY2.2%-0.3%+2.5%
5Y3.1%-1.2%+4.3%
10Y3.7%-1.3%+5.0%

1.2. Operating Efficiency of Bioqual Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioqual is operating .

  • Measures how much profit Bioqual makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • An Operating Margin of 1.6% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioqual Inc:

  • The MRQ is 1.6%. The company is operating less efficient.
  • The TTM is 1.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.5%+0.1%
TTM1.5%YOY8.6%-7.1%
TTM1.5%5Y9.4%-7.9%
5Y9.4%10Y11.3%-1.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-10.8%+12.4%
TTM1.5%0.2%+1.3%
YOY8.6%3.4%+5.2%
5Y9.4%2.7%+6.7%
10Y11.3%0.9%+10.4%
1.2.2. Operating Ratio

Measures how efficient Bioqual is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are $0.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioqual Inc:

  • The MRQ is 0.984. The company is less efficient in keeping operating costs low.
  • The TTM is 0.985. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.984TTM0.985-0.001
TTM0.985YOY0.946+0.039
TTM0.9855Y0.912+0.073
5Y0.91210Y0.912+0.001
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9841.304-0.320
TTM0.9851.343-0.358
YOY0.9461.280-0.334
5Y0.9121.251-0.339
10Y0.9121.202-0.290

1.3. Liquidity of Bioqual Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioqual is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.22 means the company has $4.22 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioqual Inc:

  • The MRQ is 4.219. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.043. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.219TTM4.043+0.176
TTM4.043YOY3.908+0.135
TTM4.0435Y3.950+0.093
5Y3.95010Y4.456-0.506
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2192.150+2.069
TTM4.0432.420+1.623
YOY3.9082.593+1.315
5Y3.9502.958+0.992
10Y4.4562.989+1.467
1.3.2. Quick Ratio

Measures if Bioqual is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Quick Ratio of 4.02 means the company can pay off $4.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioqual Inc:

  • The MRQ is 4.024. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.790. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.024TTM3.790+0.234
TTM3.790YOY3.566+0.224
TTM3.7905Y3.701+0.089
5Y3.70110Y4.243-0.542
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0241.274+2.750
TTM3.7901.279+2.511
YOY3.5661.795+1.771
5Y3.7011.997+1.704
10Y4.2432.234+2.009

1.4. Solvency of Bioqual Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioqual assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioqual to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.34 means that Bioqual assets are financed with 34.0% credit (debt) and the remaining percentage (100% - 34.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioqual Inc:

  • The MRQ is 0.340. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.363. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.363-0.023
TTM0.363YOY0.393-0.030
TTM0.3635Y0.382-0.019
5Y0.38210Y0.286+0.096
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3400.432-0.092
TTM0.3630.403-0.040
YOY0.3930.386+0.007
5Y0.3820.441-0.059
10Y0.2860.441-0.155
1.4.2. Debt to Equity Ratio

Measures if Bioqual is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioqual to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 51.6% means that company has $0.52 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioqual Inc:

  • The MRQ is 0.516. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.571. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.516TTM0.571-0.055
TTM0.571YOY0.647-0.076
TTM0.5715Y0.635-0.064
5Y0.63510Y0.438+0.197
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5160.619-0.103
TTM0.5710.563+0.008
YOY0.6470.537+0.110
5Y0.6350.635+0.000
10Y0.4380.730-0.292

2. Market Valuation of Bioqual Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioqual generates.

  • Above 15 is considered overpriced but always compare Bioqual to the Diagnostics & Research industry mean.
  • A PE ratio of 56.91 means the investor is paying $56.91 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioqual Inc:

  • The EOD is 58.945. Based on the earnings, the company is expensive. -2
  • The MRQ is 56.912. Based on the earnings, the company is expensive. -2
  • The TTM is 19.599. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD58.945MRQ56.912+2.033
MRQ56.912TTM19.599+37.313
TTM19.599YOY3.070+16.529
TTM19.5995Y12.247+7.352
5Y12.24710Y9.428+2.819
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD58.945-0.253+59.198
MRQ56.912-0.519+57.431
TTM19.599-0.112+19.711
YOY3.070-0.115+3.185
5Y12.2471.627+10.620
10Y9.4285.901+3.527
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioqual Inc:

  • The EOD is 9.611. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.280. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.328. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.611MRQ9.280+0.331
MRQ9.280TTM0.328+8.952
TTM0.328YOY286.021-285.693
TTM0.3285Y62.354-62.026
5Y62.35410Y32.454+29.900
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD9.611-1.020+10.631
MRQ9.280-1.283+10.563
TTM0.328-1.057+1.385
YOY286.021-2.859+288.880
5Y62.354-1.549+63.903
10Y32.454-2.509+34.963
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioqual is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.61 means the investor is paying $1.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioqual Inc:

  • The EOD is 1.670. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.613. Based on the equity, the company is underpriced. +1
  • The TTM is 1.604. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.670MRQ1.613+0.058
MRQ1.613TTM1.604+0.009
TTM1.604YOY1.854-0.251
TTM1.6045Y1.871-0.267
5Y1.87110Y1.406+0.464
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.6702.022-0.352
MRQ1.6132.192-0.579
TTM1.6042.153-0.549
YOY1.8542.700-0.846
5Y1.8713.450-1.579
10Y1.4064.026-2.620
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bioqual Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3070.142+116%0.708-57%0.813-62%0.784-61%
Book Value Per Share--43.40942.906+1%43.184+1%36.718+18%27.815+56%
Current Ratio--4.2194.043+4%3.908+8%3.950+7%4.456-5%
Debt To Asset Ratio--0.3400.363-6%0.393-13%0.382-11%0.286+19%
Debt To Equity Ratio--0.5160.571-10%0.647-20%0.635-19%0.438+18%
Dividend Per Share---0.125-100%0.500-100%0.672-100%0.510-100%
Eps--0.3070.267+15%0.957-68%1.036-70%0.923-67%
Free Cash Flow Per Share--1.8862.217-15%0.759+149%0.321+487%0.228+728%
Free Cash Flow To Equity Per Share--1.8862.092-10%0.259+629%-0.351+119%-0.247+113%
Gross Profit Margin--1.0001.0000%0.855+17%0.640+56%0.820+22%
Intrinsic Value_10Y_max--284.482--------
Intrinsic Value_10Y_min--39.310--------
Intrinsic Value_1Y_max--6.539--------
Intrinsic Value_1Y_min--1.434--------
Intrinsic Value_3Y_max--36.390--------
Intrinsic Value_3Y_min--6.504--------
Intrinsic Value_5Y_max--86.425--------
Intrinsic Value_5Y_min--13.941--------
Market Cap64845160.000+3%62609120.00061491100.000+2%71553510.500-13%63618387.472-2%40500681.216+55%
Net Profit Margin--0.0180.016+15%0.047-62%0.068-74%0.076-76%
Operating Margin--0.0160.015+5%0.086-82%0.094-83%0.113-86%
Operating Ratio--0.9840.9850%0.946+4%0.912+8%0.912+8%
Pb Ratio1.670+3%1.6131.604+1%1.854-13%1.871-14%1.406+15%
Pe Ratio58.945+3%56.91219.599+190%3.070+1754%12.247+365%9.428+504%
Price Per Share72.500+3%70.00068.750+2%80.000-13%67.932+3%43.684+60%
Price To Free Cash Flow Ratio9.611+3%9.2800.328+2731%286.021-97%62.354-85%32.454-71%
Price To Total Gains Ratio235.777+3%227.64778.395+190%7.514+2930%39.293+479%36.541+523%
Quick Ratio--4.0243.790+6%3.566+13%3.701+9%4.243-5%
Return On Assets--0.0050.004+17%0.013-65%0.019-75%0.027-83%
Return On Equity--0.0070.006+16%0.022-68%0.031-77%0.037-81%
Total Gains Per Share--0.3070.267+15%1.208-75%1.486-79%1.294-76%
Usd Book Value--38825580.00038375713.000+1%38624940.500+1%33579789.200+16%25247384.350+54%
Usd Book Value Change Per Share--0.3070.142+116%0.708-57%0.813-62%0.784-61%
Usd Book Value Per Share--43.40942.906+1%43.184+1%36.718+18%27.815+56%
Usd Dividend Per Share---0.125-100%0.500-100%0.672-100%0.510-100%
Usd Eps--0.3070.267+15%0.957-68%1.036-70%0.923-67%
Usd Free Cash Flow--1686752.0001982561.500-15%678678.750+149%331168.950+409%225448.650+648%
Usd Free Cash Flow Per Share--1.8862.217-15%0.759+149%0.321+487%0.228+728%
Usd Free Cash Flow To Equity Per Share--1.8862.092-10%0.259+629%-0.351+119%-0.247+113%
Usd Market Cap64845160.000+3%62609120.00061491100.000+2%71553510.500-13%63618387.472-2%40500681.216+55%
Usd Price Per Share72.500+3%70.00068.750+2%80.000-13%67.932+3%43.684+60%
Usd Profit--275026.000239255.750+15%856307.000-68%973808.250-72%848893.350-68%
Usd Revenue--15344027.00015715221.750-2%16234760.750-5%14560269.600+5%11520595.125+33%
Usd Total Gains Per Share--0.3070.267+15%1.208-75%1.486-79%1.294-76%
 EOD+4 -4MRQTTM+23 -12YOY+17 -195Y+18 -1810Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Bioqual Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1558.945
Price to Book Ratio (EOD)Between0-11.670
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.016
Quick Ratio (MRQ)Greater than14.024
Current Ratio (MRQ)Greater than14.219
Debt to Asset Ratio (MRQ)Less than10.340
Debt to Equity Ratio (MRQ)Less than10.516
Return on Equity (MRQ)Greater than0.150.007
Return on Assets (MRQ)Greater than0.050.005
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5014.708
Ma 20Greater thanMa 5072.875
Ma 50Greater thanMa 10075.950
Ma 100Greater thanMa 20074.765
OpenGreater thanClose72.500
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-02-29. Currency in USD. All numbers in thousands.

Summary
Total Assets58,865
Total Liabilities20,040
Total Stockholder Equity38,826
 As reported
Total Liabilities 20,040
Total Stockholder Equity+ 38,826
Total Assets = 58,865

Assets

Total Assets58,865
Total Current Assets31,771
Long-term Assets27,095
Total Current Assets
Cash And Cash Equivalents 11,849
Net Receivables 18,456
Other Current Assets 1,466
Total Current Assets  (as reported)31,771
Total Current Assets  (calculated)31,771
+/-0
Long-term Assets
Property Plant Equipment 26,048
Goodwill 1,028
Long-term Assets Other 19
Long-term Assets  (as reported)27,095
Long-term Assets  (calculated)27,095
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,531
Long-term Liabilities12,509
Total Stockholder Equity38,826
Total Current Liabilities
Short-term Debt 3,532
Accounts payable 1,295
Other Current Liabilities 1,920
Total Current Liabilities  (as reported)7,531
Total Current Liabilities  (calculated)6,747
+/- 783
Long-term Liabilities
Long-term Liabilities  (as reported)12,509
Long-term Liabilities  (calculated)0
+/- 12,509
Total Stockholder Equity
Common Stock16
Retained Earnings 32,486
Other Stockholders Equity 6,324
Total Stockholder Equity (as reported)38,826
Total Stockholder Equity (calculated)38,826
+/-0
Other
Cash and Short Term Investments 11,849
Common Stock Shares Outstanding 894
Current Deferred Revenue783
Liabilities and Stockholders Equity 58,865
Net Debt 3,953
Net Working Capital 24,240
Short Long Term Debt Total 15,801



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-30
> Total Assets 
4,948
4,894
5,326
4,838
4,748
5,010
4,874
5,036
5,013
5,050
0
0
0
8,688
9,034
8,786
9,411
10,152
0
0
12,233
0
11,840
11,861
13,297
13,998
12,259
11,792
11,790
11,727
11,656
14,157
15,477
15,656
15,904
16,426
17,363
16,912
17,229
18,381
19,427
19,832
0
0
22,760
23,024
23,119
24,124
26,305
26,667
26,330
27,580
28,310
45,664
47,819
47,500
49,548
50,704
51,312
50,308
53,420
53,615
61,550
61,996
63,342
65,284
64,034
61,738
61,317
61,491
59,427
58,865
58,86559,42761,49161,31761,73864,03465,28463,34261,99661,55053,61553,42050,30851,31250,70449,54847,50047,81945,66428,31027,58026,33026,66726,30524,12423,11923,02422,7600019,83219,42718,38117,22916,91217,36316,42615,90415,65615,47714,15711,65611,72711,79011,79212,25913,99813,29711,86111,840012,2330010,1529,4118,7869,0348,6880005,0505,0135,0364,8745,0104,7484,8385,3264,8944,948
   > Total Current Assets 
2,130
2,040
2,480
2,106
2,130
2,236
2,256
2,481
2,529
2,651
0
0
0
4,947
5,067
4,637
5,348
6,153
0
0
8,545
0
8,501
8,651
9,979
10,867
9,836
9,473
9,498
9,568
9,621
8,169
9,688
10,049
10,377
11,080
12,133
11,844
12,130
13,395
14,596
14,954
6,666
0
17,901
17,640
17,433
18,064
20,253
20,485
19,919
20,826
21,271
22,138
24,694
24,740
26,255
26,672
27,522
26,391
29,322
29,082
28,746
29,666
31,728
31,034
30,385
29,603
29,940
31,577
30,921
31,771
31,77130,92131,57729,94029,60330,38531,03431,72829,66628,74629,08229,32226,39127,52226,67226,25524,74024,69422,13821,27120,82619,91920,48520,25318,06417,43317,64017,90106,66614,95414,59613,39512,13011,84412,13311,08010,37710,0499,6888,1699,6219,5689,4989,4739,83610,8679,9798,6518,50108,545006,1535,3484,6375,0674,9470002,6512,5292,4812,2562,2362,1302,1062,4802,0402,130
       Cash And Cash Equivalents 
70
71
72
73
74
75
76
77
77
78
0
0
0
2,251
281
446
752
2,794
0
0
3,153
0
2,004
1,410
2,719
3,760
4,388
4,082
4,844
4,493
5,305
2,914
1,978
2,730
1,924
2,457
3,709
3,066
3,714
5,459
5,178
6,666
-6,666
0
9,288
8,129
7,967
8,451
10,161
10,347
8,378
8,426
9,208
8,340
6,135
10,038
10,256
5,869
7,489
5,028
7,720
7,983
5,240
2,389
2,184
2,199
1,933
4,364
7,279
6,436
10,162
11,849
11,84910,1626,4367,2794,3641,9332,1992,1842,3895,2407,9837,7205,0287,4895,86910,25610,0386,1358,3409,2088,4268,37810,34710,1618,4517,9678,1299,2880-6,6666,6665,1785,4593,7143,0663,7092,4571,9242,7301,9782,9145,3054,4934,8444,0824,3883,7602,7191,4102,00403,153002,7947524462812,25100078777776757473727170
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,331
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000013,331000000000000000000000000000000000000000000
       Net Receivables 
1,564
1,545
1,970
1,577
1,654
1,816
1,739
1,935
2,060
2,226
0
0
0
2,514
4,479
3,903
4,307
2,894
0
0
5,218
0
6,155
7,015
7,112
6,730
4,781
4,606
4,064
4,383
4,044
4,773
7,436
6,927
8,207
8,324
7,869
8,119
8,089
7,835
9,323
7,558
0
0
8,276
9,061
8,777
9,244
9,265
9,127
10,170
11,442
11,429
12,601
17,656
14,015
14,449
19,414
17,852
19,104
20,108
19,670
21,006
24,830
26,764
26,427
26,688
21,517
21,318
22,183
18,791
18,456
18,45618,79122,18321,31821,51726,68826,42726,76424,83021,00619,67020,10819,10417,85219,41414,44914,01517,65612,60111,42911,44210,1709,1279,2659,2448,7779,0618,276007,5589,3237,8358,0898,1197,8698,3248,2076,9277,4364,7734,0444,3834,0644,6064,7816,7307,1127,0156,15505,218002,8944,3073,9034,4792,5140002,2262,0601,9351,7391,8161,6541,5771,9701,5451,564
       Inventory 
298
257
226
251
243
222
181
160
158
134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000134158160181222243251226257298
       Other Current Assets 
197
167
212
204
158
122
260
309
233
213
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
667
786
591
691
272
482
273
392
247
299
556
660
327
101
96
731
0
0
336
450
688
369
827
1,011
1,371
957
634
1,196
903
688
1,549
1,389
2,181
2,259
1,494
1,428
2,500
2,447
2,780
2,408
1,764
3,722
1,343
2,958
1,969
1,466
1,4661,9692,9581,3433,7221,7642,4082,7802,4472,5001,4281,4942,2592,1811,3891,5496889031,1966349571,3711,01182736968845033600731961013276605562992473922734822726915917866670000000000000000213233309260122158204212167197
   > Long-term Assets 
2,818
2,853
2,846
2,732
2,618
2,773
2,618
2,555
2,484
2,400
0
0
0
3,741
3,967
4,149
4,063
4,000
0
0
3,689
0
3,339
3,210
3,318
3,132
1,498
2,319
2,292
2,159
2,035
5,988
5,789
5,607
5,526
5,346
5,231
5,068
5,100
4,986
4,831
4,878
-6,666
0
4,859
5,384
5,686
6,061
6,051
6,182
6,411
6,755
7,039
23,527
23,125
22,760
23,293
24,032
23,790
23,917
24,098
24,533
32,804
32,330
31,614
34,250
33,649
32,136
31,377
29,915
28,506
27,095
27,09528,50629,91531,37732,13633,64934,25031,61432,33032,80424,53324,09823,91723,79024,03223,29322,76023,12523,5277,0396,7556,4116,1826,0516,0615,6865,3844,8590-6,6664,8784,8314,9865,1005,0685,2315,3465,5265,6075,7895,9882,0352,1592,2922,3191,4983,1323,3183,2103,33903,689004,0004,0634,1493,9673,7410002,4002,4842,5552,6182,7732,6182,7322,8462,8532,818
       Property Plant Equipment 
1,504
1,617
1,607
1,597
1,507
1,413
1,413
1,466
1,516
1,527
0
0
0
3,136
3,362
3,544
3,458
3,344
0
0
2,895
0
2,545
2,416
2,482
2,295
1,498
1,394
1,268
1,135
1,011
3,622
3,421
3,276
3,244
3,100
2,986
2,860
2,894
2,783
2,821
2,991
0
0
2,948
3,476
3,780
4,157
4,288
4,421
4,653
4,999
5,294
21,784
21,385
21,022
21,496
22,236
21,997
22,125
22,958
23,392
31,645
31,171
30,586
33,203
32,602
31,089
30,349
28,868
27,459
26,048
26,04827,45928,86830,34931,08932,60233,20330,58631,17131,64523,39222,95822,12521,99722,23621,49621,02221,38521,7845,2944,9994,6534,4214,2884,1573,7803,4762,948002,9912,8212,7832,8942,8602,9863,1003,2443,2763,4213,6221,0111,1351,2681,3941,4982,2952,4822,4162,54502,895003,3443,4583,5443,3623,1360001,5271,5161,4661,4131,4131,5071,5971,6071,6171,504
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,028001,0281,0281,0281,0281,0281,0281,0281,0281,0281,02800000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
664
548
427
401
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000401427548664000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,342
237
201
152
116
91
55
52
50
47
44
0
0
37
34
32
29
26
24
21
19
16
14
11
9
6
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000013691114161921242629323437004447505255911161522012371,3420000000000000000000000000000000
       Long-term Assets Other 
714
636
741
638
613
863
1,006
890
769
763
0
0
0
605
605
605
605
656
0
0
794
0
794
794
836
836
-1,498
925
1,024
1,024
1,024
1,024
1,102
1,102
1,102
1,102
1,125
1,125
1,125
1,125
934
815
-6,666
0
846
846
846
846
708
708
708
708
701
701
701
701
763
763
763
763
112
112
130
130
-31,614
19
19
19
-31,377
19
19
19
191919-31,377191919-31,6141301301121127637637637637017017017017087087087088468468468460-6,6668159341,1251,1251,1251,1251,1021,1021,1021,1021,0241,0241,0241,024925-1,4988368367947940794006566056056056050007637698901,006863613638741636714
> Total Liabilities 
1,452
1,384
1,758
1,249
1,086
1,300
1,045
1,143
1,045
995
0
0
0
2,041
2,103
1,619
1,890
2,510
0
0
2,070
0
1,725
1,711
2,924
3,354
1,646
1,483
1,448
1,235
912
3,398
4,415
4,156
4,030
4,251
4,574
3,895
3,522
4,439
4,073
3,479
0
0
3,845
3,323
3,226
3,427
3,464
2,956
2,548
3,304
2,777
19,773
21,658
20,615
21,366
20,752
20,881
18,901
19,890
18,708
26,621
26,211
25,670
26,228
24,578
23,422
23,703
22,978
20,876
20,040
20,04020,87622,97823,70323,42224,57826,22825,67026,21126,62118,70819,89018,90120,88120,75221,36620,61521,65819,7732,7773,3042,5482,9563,4643,4273,2263,3233,845003,4794,0734,4393,5223,8954,5744,2514,0304,1564,4153,3989121,2351,4481,4831,6463,3542,9241,7111,72502,070002,5101,8901,6192,1032,0410009951,0451,1431,0451,3001,0861,2491,7581,3841,452
   > Total Current Liabilities 
1,433
1,379
1,568
1,086
946
1,204
962
1,089
1,023
985
0
0
0
1,573
1,661
1,194
1,465
2,181
0
0
1,491
0
1,192
1,197
2,477
2,898
1,646
1,483
1,448
1,235
912
1,476
2,524
2,285
2,182
2,684
3,091
2,468
2,179
3,084
3,072
2,567
0
0
3,100
2,601
2,531
2,748
3,464
2,956
2,548
3,304
2,777
5,083
7,290
7,047
7,682
6,635
7,585
6,446
8,517
8,056
9,502
9,754
9,765
8,280
7,026
6,871
8,297
7,626
7,356
7,531
7,5317,3567,6268,2976,8717,0268,2809,7659,7549,5028,0568,5176,4467,5856,6357,6827,0477,2905,0832,7773,3042,5482,9563,4642,7482,5312,6013,100002,5673,0723,0842,1792,4683,0912,6842,1822,2852,5241,4769121,2351,4481,4831,6462,8982,4771,1971,19201,491002,1811,4651,1941,6611,5730009851,0231,0899621,2049461,0861,5681,3791,433
       Short-term Debt 
898
891
811
475
387
645
302
379
479
364
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
276
276
276
276
289
289
289
289
303
303
0
0
317
317
317
301
250
168
86
0
0
0
0
0
0
0
0
0
3,303
3,217
3,256
3,170
3,071
3,539
3,071
3,196
3,442
2,598
3,476
3,532
3,5323,4762,5983,4423,1963,0713,5393,0713,1703,2563,2173,303000000000861682503013173173170030330328928928928927627627627627100000000000000003160000364479379302645387475811891898
       Short Long Term Debt 
0
0
0
0
0
0
302
379
479
364
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
567
489
317
301
250
168
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000861682503013174895670000000000000000000000000000000000364479379302000000
       Accounts payable 
157
193
201
208
117
209
168
326
210
197
0
0
0
569
439
436
392
409
0
0
401
0
340
482
599
581
402
556
313
518
310
391
618
303
611
489
807
592
647
1,336
1,222
1,293
0
0
1,241
891
1,305
1,177
1,804
1,556
1,017
1,900
1,312
909
1,265
1,764
2,476
1,667
2,233
864
2,108
1,758
3,123
2,923
3,289
1,543
1,515
1,119
1,594
3,077
1,499
1,295
1,2951,4993,0771,5941,1191,5151,5433,2892,9233,1231,7582,1088642,2331,6672,4761,7641,2659091,3121,9001,0171,5561,8041,1771,3058911,241001,2931,2221,336647592807489611303618391310518313556402581599482340040100409392436439569000197210326168209117208201193157
       Other Current Liabilities 
377
295
555
403
442
350
492
384
334
424
0
0
0
1,004
99
758
1,073
1,771
0
0
931
0
626
635
1,016
582
1,244
927
1,134
717
602
815
1,630
1,706
1,295
1,920
1,995
1,587
1,244
1,459
1,547
971
0
0
1,541
1,393
909
1,270
1,410
1,231
1,446
1,404
1,465
4,174
6,025
5,283
5,206
4,968
5,351
5,582
2,231
1,824
1,579
1,749
2,240
1,331
1,764
2,029
2,304
1,242
1,933
1,920
1,9201,9331,2422,3042,0291,7641,3312,2401,7491,5791,8242,2315,5825,3514,9685,2065,2836,0254,1741,4651,4041,4461,2311,4101,2709091,3931,541009711,5471,4591,2441,5871,9951,9201,2951,7061,6308156027171,1349271,2445821,0166356260931001,7711,073758991,004000424334384492350442403555295377
   > Long-term Liabilities 
19
5
190
163
140
96
83
53
22
10
0
0
0
467
442
426
425
330
0
0
579
0
533
514
447
456
0
0
0
0
0
1,921
1,891
1,871
1,848
1,567
1,483
1,427
1,342
1,354
1,001
912
0
0
745
722
695
680
0
0
0
0
0
14,690
14,368
13,569
13,684
14,117
13,296
12,455
11,373
10,652
17,119
16,456
15,905
17,948
17,552
16,551
15,406
15,352
13,521
12,509
12,50913,52115,35215,40616,55117,55217,94815,90516,45617,11910,65211,37312,45513,29614,11713,68413,56914,36814,69000000680695722745009121,0011,3541,3421,4271,4831,5671,8481,8711,8911,921000004564475145330579003304254264424670001022538396140163190519
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
791
823
853
878
969
208
208
208
413
413
413
413
58
58
58
58
251
251
251
251
240
0
0
0
0002402512512512515858585841341341341320820820896987885382379164960254953100000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
531
549
602
649
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000064960254953100000000000000000000000000000000000000000000
> Total Stockholder Equity
3,496
3,510
3,568
3,589
3,662
3,709
3,829
3,893
3,968
4,055
0
0
0
6,648
6,931
7,166
7,521
7,642
0
0
10,163
0
10,115
10,150
10,373
10,644
10,444
10,152
10,194
10,365
10,571
10,760
11,062
11,501
11,874
12,175
12,789
13,017
13,708
13,943
15,354
16,353
16,353
0
18,915
19,702
19,893
20,697
22,050
22,888
22,929
23,398
24,564
25,892
26,161
26,885
28,182
29,952
30,431
31,407
33,530
34,907
34,928
35,785
37,672
39,056
39,455
38,316
37,614
38,513
38,551
38,826
38,82638,55138,51337,61438,31639,45539,05637,67235,78534,92834,90733,53031,40730,43129,95228,18226,88526,16125,89224,56423,39822,92922,88822,05020,69719,89319,70218,915016,35316,35315,35413,94313,70813,01712,78912,17511,87411,50111,06210,76010,57110,36510,19410,15210,44410,64410,37310,15010,115010,163007,6427,5217,1666,9316,6480004,0553,9683,8933,8293,7093,6623,5893,5683,5103,496
   Common Stock
16
16
16
16
16
16
16
16
16
16
0
0
0
16
16
16
16
16
0
0
16
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
0
0
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
1616161616161616161616161616161616161616161616161616161600161616161616161616161616161616161616161601600161616161600016161616161616161616
   Retained Earnings 
-3,292
-3,282
-3,230
-3,209
-3,137
-3,090
-2,971
-2,911
-2,837
-2,749
0
0
0
282
564
800
1,151
1,260
0
0
3,800
0
3,752
3,834
4,058
4,329
4,136
3,856
3,892
4,064
4,270
4,459
4,760
5,200
5,573
5,874
6,488
6,716
7,407
7,642
9,054
10,053
0
0
12,615
13,402
13,593
14,392
15,741
16,576
16,614
17,079
18,242
19,567
19,833
20,553
21,847
23,614
24,091
25,067
27,190
28,567
28,589
29,445
31,333
32,716
33,116
31,976
31,274
32,173
32,211
32,486
32,48632,21132,17331,27431,97633,11632,71631,33329,44528,58928,56727,19025,06724,09123,61421,84720,55319,83319,56718,24217,07916,61416,57615,74114,39213,59313,40212,6150010,0539,0547,6427,4076,7166,4885,8745,5735,2004,7604,4594,2704,0643,8923,8564,1364,3294,0583,8343,75203,800001,2601,151800564282000-2,749-2,837-2,911-2,971-3,090-3,137-3,209-3,230-3,282-3,292
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000-691-690-690-692-692-692-693-693-6990
   Other Stockholders Equity 
6,772
6,776
6,782
6,782
6,783
6,783
6,785
6,788
6,788
6,788
0
0
0
6,350
6,351
6,351
6,354
6,366
0
0
6,347
0
6,347
6,299
6,299
6,299
6,291
6,280
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,285
6,284
6,284
0
0
6,284
6,284
6,284
6,289
6,293
6,296
6,299
6,302
6,306
6,309
6,312
6,316
6,319
6,322
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,324
6,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3246,3226,3196,3166,3126,3096,3066,3026,2996,2966,2936,2896,2846,2846,284006,2846,2846,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2806,2916,2996,2996,2996,34706,347006,3666,3546,3516,3516,3500006,7886,7886,7886,7856,7836,7836,7826,7826,7766,772



Balance Sheet

Currency in USD. All numbers in thousands.